(TVTX) – Corporate News
-
Travere Therapeutics (TVTX) and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
-
Travere Therapeutics (TVTX) and CSL Vifor Report Positive CHMP Opinion for sparsentan
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TVTX Stock Lookup